ANAPTYSBIO, INC — Director's Dealing 2017

Mar 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-02-24

Reporting Person: MOYLE MATTHEW (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-24	Employee Stock Option (right to buy)	$24.60	A	75000	Acquired	2027-02-23	Common Stock (75000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to
1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the
Reporting Person on each vesting date.